Minoxidil/finasteride, or finasteride/minoxidil, sold under the brand name MorrF or Morr F, is a combination of the KATP potassium channel opener minoxidil and the 5α-reductase inhibitor finasteride which is approved and used in the treatment of alopecia (hair loss) in India.[1][2][3] It is used topically.[1] The drug was developed by Intas Pharmaceuticals and Jina Pharmaceuticals and was introduced in 2015.[1]
References
- ↑ 1.0 1.1 1.2 "Jina Pharmaceuticals/Intas Pharmaceuticals". AdisInsight. 2 September 2015. Retrieved 23 October 2025.
- ↑ Ramkar S, Kaurav M, Sudheesh MS, Pandey RS (January 2023). "Enhanced skin penetration of Finasteride loaded DMSO-liposomes for the treatment of androgenic alopecia: comparison with conventional liposomes". Drug Development and Industrial Pharmacy. 49 (1): 52–61. doi:10.1080/03639045.2023.2182122. PMID 36803490.
- ↑ van Hoogevest P, Tiemessen H, Metselaar JM, Drescher S, Fahr A (2021). "The Use of Phospholipids to Make Pharmaceutical Form Line Extensions". European Journal of Lipid Science and Technology. 123 (4) 2000297. doi:10.1002/ejlt.202000297. ISSN 1438-7697. Retrieved 23 October 2025.
Template:Other dermatological preparations Template:Androgens and antiandrogens Template:Ion channel modulators